Published in Biotech Business Week, November 9th, 2009
"A key to the selection of Medversant was our advanced provider data management platform and patented, game-changing process for continuous credentials verification, AutoVerifi™, (U.S. Patent 7,529,682)," says Matthew Haddad, Medversant's president and CEO. "Our technology finds...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.